Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
7.69B | 5.98B | 5.90B | 6.80B | 4.94B | Gross Profit |
757.01M | 660.26M | 569.52M | 646.56M | 559.76M | EBIT |
152.65M | 110.56M | 66.62M | 145.21M | 178.78M | EBITDA |
236.06M | 236.74M | 177.89M | 261.41M | 288.73M | Net Income Common Stockholders |
50.74M | 25.73M | 14.29M | 77.38M | 124.08M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.04B | 1.07B | 760.66M | 648.84M | 417.87M | Total Assets |
6.08B | 5.57B | 4.84B | 4.94B | 4.28B | Total Debt |
1.01B | 773.63M | 539.51M | 551.74M | 451.26M | Net Debt |
-33.26M | -297.37M | -221.15M | -97.09M | 33.38M | Total Liabilities |
3.79B | 3.28B | 2.58B | 2.67B | 2.15B | Stockholders Equity |
2.08B | 2.11B | 2.09B | 2.12B | 2.00B |
Cash Flow | Free Cash Flow | |||
0.00 | 85.46M | 133.28M | 139.43M | -312.10M | Operating Cash Flow |
0.00 | 198.56M | 204.76M | 252.55M | -162.60M | Investing Cash Flow |
0.00 | -112.53M | -74.17M | -116.33M | -143.78M | Financing Cash Flow |
0.00 | 209.40M | -11.52M | 96.41M | 82.48M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | HK$226.06M | 4.45 | 2.42% | 51.64% | 28.60% | 97.00% | |
65 Neutral | $65.48B | 13.85 | 6.22% | 1.93% | -2.82% | 11.93% | |
63 Neutral | $766.59M | 8.52 | 4.79% | 3.75% | 1.11% | -32.36% | |
52 Neutral | $26.36B | ― | -17.87% | ― | -17.35% | -278.88% | |
50 Neutral | HK$1.82B | 12.24 | 4.99% | 21.37% | 10.66% | 3.88% | |
49 Neutral | HK$35.19M | ― | -22.83% | ― | 0.23% | -43.18% | |
27 Underperform | HK$98.95M | ― | -252.43% | ― | -66.81% | 21.93% |
Chinney Alliance Group Limited has announced its upcoming Annual General Meeting (AGM) scheduled for June 6, 2025, in Hong Kong. The meeting will cover key agenda items such as reviewing the company’s audited financial statements for the year ended December 31, 2024, declaring a final dividend, re-electing directors, and re-appointing the auditor. Additionally, a resolution will be considered to grant the directors a mandate to issue additional shares, with certain conditions and limitations, to enhance the company’s capital management flexibility.
Chinney Alliance Group Limited reported its financial results for the year ended December 31, 2024, showing a significant increase in revenue to HK$7,692,498,000 from HK$5,981,640,000 in 2023. Despite a rise in administrative expenses and finance costs, the company’s profit for the year increased to HK$82,500,000, up from HK$56,447,000 in the previous year, indicating improved operational performance. However, the total comprehensive income for the year decreased to HK$26,864,000 from HK$67,769,000, primarily due to a deficit on revaluation of leasehold land and owned buildings.
Chinney Alliance Group Limited has announced a final ordinary cash dividend of HKD 0.025 per share for the financial year ending December 31, 2024. The dividend will be paid on July 9, 2025, following shareholder approval on June 6, 2025. The ex-dividend date is set for June 11, 2025, with the book closure period running from June 13 to June 18, 2025. This announcement reflects the company’s commitment to returning value to its shareholders.
Chinney Alliance Group Limited has announced a board meeting scheduled for March 25, 2025, to approve the final results for the year ending December 31, 2024, and to consider the recommendation of a final dividend. This meeting could impact the company’s financial strategy and shareholder returns, reflecting its ongoing operational assessments and potential market positioning.
Chinney Group, consisting of Chinney Investments, Hon Kwok Land Investment, Chinney Alliance Group, and Chinney Kin Wing Holdings, announced the passing of its founder, Dr. James Sai-Wing Wong, at the age of 86. Despite his passing, the company assures stakeholders that its operations will continue as usual, guided by the existing business strategies, and that there will be no impact on its operations. The company extends condolences to Dr. Wong’s family and acknowledges his significant contributions and leadership.